DelSiTech's proprietary Silica Matrix technology platform is highly versatile and has demonstrated compatibility with a wide range of therapeutic agents, including small molecules, peptides, and large biologics. The product can be formulated to release drug over days, weeks, or even months, providing patients and caregivers with possible access to long-lasting treatment options. As an additional benefit of fewer doses, our natural Silica Matrix platform also supports sustainability by helping to reduce medical waste — including waste that might otherwise end up in the environment. Partnering with and licensing our proprietary slow-releasing Silica Matrix drug delivery technology to biopharmaceutical and pharmaceutical partner companies.
